Corrigendum to 'Controlling chitosan-based encapsulation for protein and vaccine delivery' [Biomaterials 35 (2014) 4382-4389], doi:10.1016/j.biomaterials.2014.01.078;Controlling chitosan-based encapsulation for protein and vaccine delivery

Biomaterials

Volumn 35, Issue 14, 2014, Pages 4382-4389

  Koppolu, Bhanu prasanth ^a   Smith, Sean G ^a   Ravindranathan, Sruthi ^a   Jayanthi, Srinivas ^a   Suresh Kumar, Thallapuranam K ^a   Zaharoff, David A ^a  

^a UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Chitosan particles; Microencapsulation; Nanoencapsulation; Precipitation coacervation; Protein encapsulation; Vaccine delivery

Indexed keywords

CHITOSAN; EFFICIENCY; ENCAPSULATION; HYDRATION; MICROENCAPSULATION; MOLECULAR WEIGHT; PARTICLE SIZE; POLYDISPERSITY; PRECIPITATION (CHEMICAL); PROTEINS; SALTS; TARGETED DRUG DELIVERY; VACCINES;

CHITOSAN CONCENTRATION; CHITOSAN PARTICLES; HIGH PROTEIN LOADINGS; NANO-ENCAPSULATION; NANO/MICROENCAPSULATION; POLYDISPERSITY INDICES; PROTEIN ENCAPSULATION; VACCINE DELIVERY;

CONTROLLED DRUG DELIVERY;

ANION; BOVINE SERUM ALBUMIN; CHITOSAN; CONCANAVALIN A; INSULIN; OVALBUMIN; PROTEIN; SODIUM CHLORIDE; VACCINE;

ARTICLE; CHEMICAL COMPOSITION; COACERVATION; CONCENTRATION (PARAMETERS); CONTROLLED RELEASE FORMULATION; DISPERSION; DRUG DELIVERY SYSTEM; ENCAPSULATION; HYDRATION; MEMBRANE MICROPARTICLE; MOLECULAR WEIGHT; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; PROTEIN SECRETION; ULTRASOUND;

CHITOSAN PARTICLES; MICROENCAPSULATION; NANOENCAPSULATION; PRECIPITATION-COACERVATION; PROTEIN ENCAPSULATION; VACCINE DELIVERY;

CALORIMETRY; CHEMICAL PRECIPITATION; CHITOSAN; DRUG DELIVERY SYSTEMS; FLUORESCEIN-5-ISOTHIOCYANATE; IMMOBILIZED PROTEINS; MOLECULAR WEIGHT; OSMOLAR CONCENTRATION; PARTICLE SIZE; PROTEIN BINDING; SERUM ALBUMIN, BOVINE; SOLUTIONS; SONICATION; SULFATES; THERMODYNAMICS; VACCINES; WATER;

EID: 84896792100     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.09.029     Document Type: Erratum

References (32)

1. Kas H.S. Chitosan: properties, preparations and application to microparticulate systems. J Microencapsul 1997, 14:689-711.
2. Sinha V.R., Singla A.K., Wadhawan S., Kaushik R., Kumria R., Bansal K., et al. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004, 274:1-33.
3. Chandy T., Sharma C.P. Chitosan as a biomaterial. Biomater Artif Cells Artif Organs 1990, 18:1-24.
4. Chandy T., Sharma C.P. Chitosan matrix for oral sustained delivery of ampicillin. Biomaterials 1993, 14:939-944.
5. Mao H.Q., Roy K., Troung-Le V.L., Janes K.A., Lin K.Y., Wang Y., et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001, 70:399-421.
6. Janes K.A., Fresneau M.P., Marazuela A., Fabra A., Alonso M.J. Chitosan nanoparticles as delivery systems for doxorubicin. J Control Release 2001, 73:255-267.
7. Gan Q., Wang T. Chitosan nanoparticle as protein delivery carrier-systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B Biointerfaces 2007, 59:24-34.
8. Xu Y., Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm 2003, 250:215-226.
9. Nagamoto T., Hattori Y., Takayama K., Maitani Y. Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm Res 2004, 21:671-674.
10. Seferian P.G., Martinez M.L. Immune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine 2000, 19:661-668.
11. Zaharoff D.A., Rogers C.J., Hance K.W., Schlom J., Greiner J.W. Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine 2007, 25:2085-2094.
12. Koppolu B., Zaharoff D.A. The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells. Biomaterials 2013, 34:2359-2369.
13. Lim S.T., Martin G.P., Berry D.J., Brown M.B. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. J Control Release 2000, 66:281-292.
14. Siepmann J., Faisant N., Akiki J., Richard J., Benoit J.P. Effect of the size of biodegradable microparticles on drug release: experiment and theory. J Control Release 2004, 96:123-134.
15. Bugamelli F., Raggi M.A., Orienti I., Zecchi V. Controlled insulin release from chitosan microparticles. Arch Pharm 1998, 331:133-138.
16. Ko J.A., Park H.J., Hwang S.J., Park J.B., Lee J.S. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm 2002, 249:165-174.
17. van der Lubben I.M., Verhoef J.C., van Aelst A.C., Borchard G., Junginger H.E. Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials 2001, 22:687-694.
18. Huang Y., Yeh M., Chiang C. Formulation factors in preparing BTM-chitosan microspheres by spray drying method. Int J Pharm 2002, 242:239-242.
19. Berthold A., Cremer K., Kreuter J. Preparation and charecterization of chitosan microspheres as drug carrier for prednisolone sodium phospate as model for anti-inflammatory drugs. J Control Release 1996, 39:17-25.
20. Gordon S., Saupe A., McBurney W., Rades T., Hook S. Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery. J Pharm Pharmacol 2008, 60:1591-1600.
21. Terbojevich M., Cosani A., Muzzarelli R.A.A. Molecular parameters of chitosans depolymerized with the aid of papain. Carbohydr Polym 1996, 29:63-68.
22. Hu B., Pan C., Sun Y., Hou Z., Ye H., Zeng X. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins. J Agric Food Chem 2008, 56:7451-7458.
23. Gan Q., Wang T., Cochrane C., McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces 2005, 44:65-73.
24. Kobiasi M.A., Chua B.Y., Tonkin D., Jackson D.C., Mainwaring D.E. Control of size dispersity of chitosan biopolymer microparticles and nanoparticles to influence vaccine trafficking and cell uptake. J Biomed Mater Res A 2012, 100:1859-1867.
25. Ozbas-Turan S., Akbuga J., Aral C. Controlled release of interleukin-2 from chitosan microspheres. J Pharm Sci 2002, 91:1245-1251.
26. Pan Y., Li Y.J., Zhao H.Y., Zheng J.M., Xu H., Wei G., et al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 2002, 249:139-147.
27. Tang E.S., Huang M., Lim L.Y. Ultrasonication of chitosan and chitosan nanoparticles. Int J Pharm 2003, 265:103-114.
28. Genta I., Perugini P., Pavanetto F. Different molecular weight chitosan microspheres: influence on drug loading and drug release. Drug Dev Ind Pharm 1998, 24:779-784.
29. Cacace M.G., Landau E.M., Ramsden J.J. The Hofmeister series: salt and solvent effects on interfacial phenomena. Q Rev Biophys 1997, 30:241-277.
30. Record M.T., Guinn E., Pegram L., Capp M. Introductory lecture: interpreting and predicting Hofmeister salt ion and solute effects on biopolymer and model processes using the solute partitioning model. Faraday Discuss 2013, 160:9-44. discussion 103-120.
31. Tokumitsu H., Ichikawa H., Fukumori Y. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization. Pharm Res 1999, 16:1830-1835.
32. Chang K.L.B., Lin J. Swelling behavior and the release of protein from chitosan pectin composite particles. Carbohydr Polym 2000, 43:163-169.